Sign in

CIK 0001000694 · Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222816046
Phone
240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 8-K Event Exit or restructuring costs
  9. 424B5 Offering Prospectus
  10. 8-K Event Material agreement
  11. UPLOAD Other SEC-generated Letter
  12. 8-K Event Executive or director change
  13. 8-K Event Executive or director change
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. 10-K/A Report 10-K/A
  18. 8-K Event Regulation FD disclosure
  19. UPLOAD Other SEC-generated Letter
  20. 10-Q Report Quarterly Report

Page 62 of 83 · 1,649 filings